Company / Debt per Share
Arcus Biosciences, Inc. Debt per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$1.07
FY2025
5-year range
$0.00 / $1.07
FY2023-FY2025
Trend
+68.9%
vs FY2024
Sector context
#58 of 82
Health Care
What the data says
At $1.07, Arcus Biosciences, Inc.'s debt per share ranks #25 of 82 in the Health Care sector. Increased from $0.00 to $1.07 over the past 2 years.
Based on SEC 10-K filings.
1.07 in FY2025.
Increased from $0.00 to $1.07 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#25 of 82 in Health CareTop 29% of 82This company $1.07 Sector average $151.59
▼
-99.3% below sector average
Key checks
Key Insights
- In FY2025, debt per share increased 68.9% year-over-year.
- Ranks #58 out of 82 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -0.93 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.07 | +68.9% |
| FY2024 | $0.64 | - |
| FY2023 | $0.00 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026